Gap Cancer-302: Identify tissue-specific surrogate end-points for space radiation induced pre-malignancy and shared biology with other degenerative diseases.
This Gap was merged into the following Gap:
Cancer-204: Evaluate the sex-specific risks of space radiation exposure on cancer outcomes.

Merge Rationale
No rationale available.